# Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-01 14:29 UTC · Category: Business · Sources: 6 · Current Velocity: 3.67

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Lupus Foundation of America | Novartis, Bristol Myers Squibb pause CAR-T trials for lupus and other autoimmune diseases for safety reviews | 2026-09-01 08:22 | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxOU1dDSUp0ckRKZmhyWE82MndqWm42Z0FXZDB2X19ETmVLcjZHUkJRYk5ia0d0WFNCRkE4SGRZR25qN3JEeWN6M0c1MjkwMVNwcXhMVnNpczFteE5KQkNQUll4ajdTLW03R2NVOUdSVzRBNU55cktydnhWRl9vOWlHYXZucFN2c0czVnIzVFFHcW5JMGY0YnlwMzNzNkxXbm5yVUQ3VXZlaENHajJXMnJtRkpJU2c?oc=5) |
| proactiveinvestors.co.uk | Panmure Liberum says OxfordBiomedica share fall overdone after Novartis and BMS pause trials | 2026-09-01 08:22 | [Source Link](https://news.google.com/rss/articles/CBMi-AFBVV95cUxNLVRqaGpua1Jia1pZUHB4eFB0NHJrS2V6ZmM3RkRqVmtUT2ZNMllacTZPbUY3NmxaV2FxVXZvelZlbl8wSDExbzVhcVhLT2M5YU5MS1ZvZ3IzVWNDMXlpLWxNRXJjU2k0Zm9YVDRiejBfd3drWFp6ODJ4dDlBcnZXNm83dzVuUkptM3A0c0NCN0tDRlNfaTduRm5HeDBRSllXejRlOHZ3SVZVZHRpdlVtZkUtT2ZZM0RaYjh1Vlo2M3NRZ1FRc0ZRbS1WTGZOcTlpNjNHRFcyWXVPeHZGdEhMWVNqci10TUppanpiWnl3OGJXWlo1ZEMtbw?oc=5) |
| EMJ | Novartis halts eight CAR-T cell therapy trials after deaths | 2026-09-01 08:22 | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxNUWNPSUpENFBScmtrZmNEZFZjZWdxTXFIcHFMMFRBWUJLenNzSzh2V3JSTk1vUjlTRmN1VVhCU3ZhaE9wQUQ4d1hhZHcwT213cmxyQjU3d21WWkVENlFSY0UySHI2cERRT19FRFJTMUJXZ1dxb1FlejlqaGNHZDBoaUtJeWpUSmZ0Zl8ybUZTQVYwMmVqOGNJSDIyUmVjbGVEbi0w?oc=5) |
| Seeking Alpha | Novartis halts autoimmune CAR-T trials following three patient deaths: WSJ (NVS:NYSE) | 2026-09-01 08:22 | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxPWlpHcnVRZkdtd0VkcGIxZkQ4R3JhMEtKRzdSZUpQdjJTTXlDMUdDaUhVSkktUnN3c2l1d0xpVzEtakVCMVJpdklyME04Yi1VRmctNzJyUU1XR001QUM3TWdTcEt2di0tbk94VzZjdUY4c0g0Vi1oUjVHTm9ka3FWSXBvS3ltejB4UkVyOUNlSE15ZnpoaDRnVXo4MUpWTDVsWXBtcDZ1Y0tkZ1FpejdvZQ?oc=5) |
| BioSpace | Novartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety events | 2026-09-01 08:22 | [Source Link](https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTVg5TnhRV3BnZENvQXRkV1NFQ2QzUW1NVERoblBOS29ReG1KZDFHRkdqV2hFdGR0TTlsNkVCV29WZkplSXF2U3ZBN09Fb01ObUhqNWVOZDFqUHNmQ2hiYXo1QmFkQXlpOGNFY2dqVW12RHlVUVNjeGR6MDF6VkxGaHE4MzNNejE4bnVLQmQ4NXM1NDhsZUNJQ2laUlhqM1Z2NXdJZDJoZ0pZeUlFWjRoYTZlR0U1QmpQMU95V0tqWHZVZw?oc=5) |
| STAT | Pharmalittle: We're reading about Novartis and Bristol pausing cell therapy trials, a $480K cancer drug, and more | 2026-09-01 08:22 | [Source Link](https://news.google.com/rss/articles/CBMiygFBVV95cUxORjlpbmM4OGNPWUh6WHo4S0tEVE5ZODExUzlUaER2OHd0OThxSFBqU0xRNDRCdEh3UGJUZ3F0ckprdE41YnlXOUt2VS0zeWFKeE0xRXdXbHFUdERSaWhtcUR0dThJU1JvdmdVRzk5a3FBZmNULV95akNRN1hoSlRzQ3RQc2hYcFMzc29NaUpiZ20yN2I3elh4ZVhNOHdoaEJ5RmJhN3RnbE9MOWNpZ3haVHJKal8tNzRiMVJTZC1xZy00Q0huVzRyXzFR?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-01/novartis-bristol-myers-pause-autoimmune-car-t-trials-due-to-safety-concerns*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*